这家港股18A内讧,灵魂人物离场。

医药财经
Yesterday

永泰生物成立于2006年11月,由谭铮创立,核心技术领袖王歈(曾任CEO、首席科技官)是中国较早注册的细胞免疫治疗企业,公司于2020年7月在港交所借力港股18A通道IPO上市,募集资金接近11亿港元。根据最新公开信息,永泰生物发生了核心技术领袖兼创始人之一王歈博士离场事件。1. 创始人辞任及原因王歈博士(公司核心创始人)于2025年5月30日发布公告,宣布辞去执行董事、首席执行官及首席科技官职务...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10